Kardi Ai

Name

Kardi Ai

Legal name

KARDI AI Technologies s.r.o.

Website

https://kardi.ai

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Cardiac Monitoring Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)

akta.pro secondary industries

ECG/EKG & Heart Rhythm Monitors (Consumer) (CRACAQAC), Cardiology Telemedicine Platforms (HLALAGAB), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

Keywords

• AI ECG monitoring
• Cardiac arrhythmia detection
• Wearable heart monitor
• Preventive cardiology
• Telemedicine ECG

Headquarters

HQ city

Olomouc

HQ country

Czechia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure, Supply Chain

Revenue model

1. Hardware + Software Subscription Bundle: Kardi AI operates on a subscription model bundled with hardware (chest strap device). The device is provided as part of the first subscription and becomes user property after purchase. Subscriptions are offered in various periods (monthly, annual, or multi-year) with the option to pay in monthly installments. The subscription includes device usage, cloud data storage, AI analysis, and access to the mobile application.
2. Insurance Reimbursement: The service is reimbursable by Czech health insurance companies, providing an additional revenue pathway and reducing consumer cost barriers. This reimbursement model supports adoption among Czech patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Kardi Ai provides an AI-powered long-term ECG monitoring medical device (EU MDR Class IIa certified) consisting of a wearable chest strap sensor paired with a certified mobile application. The system performs automated single-lead ECG recording and analysis, detecting seven heart rhythm disorders and delivering AI-evaluated results to users within 5 minutes while generating detailed PDF reports for cardiologists.

Product overview

Kardi Ai is a preventive heart monitoring medtech solution comprising three integrated components: (1) a certified Class IIa medical device combining a hardware chest strap with an AI-powered mobile app for long-term ECG monitoring; (2) cloud-based AI analysis that evaluates heart rhythm data and detects 7 cardiac disorders; and (3) Beatwell, a companion wellness app for everyday heart rhythm tracking. The product enables users to measure ECG anytime, anywhere, with AI-generated results delivered within 5 minutes and detailed PDF reports shared with cardiologists.

Differentiator

Problem solved

Functional benefit

Brands

• Beatwell: A wellness-focused heart rhythm overview solution providing simple feedback through a color-coded scale. It is not a medical device but an accessible solution for everyday monitoring and supporting an active lifestyle.

Products and services

• Kardi Ai AI-powered long-term ECG monitoring medical device (EU MDR Class IIa certified) combining a chest strap sensor with a mobile application for iOS and Android. Detects 7 heart rhythm disorders including atrial fibrillation using certified AI, delivers results within 5 minutes, and generates detailed PDF reports for physicians. Includes 78 days of measurement capability.
• Beatwell

Quantifiable outcome

• 29% of users discovered arrhythmia through Kardi Ai monitoring
• +4 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core and support.

• MedicovercoreStrategic or Co-development PartnerMedicover signed expansion partnership agreement with Kardi AI for providing cardiac monitoring services in target European markets including Bulgaria, Poland, and Slovakia.
• HaelancoreStrategic or Co-development PartnerHaelan partnered with Kardi AI for cardiac monitoring service expansion across CEE markets as part of the company's multi-country market entry strategy.
• AcibademcoreStrategic or Co-development PartnerAcibadem, international healthcare provider, signed partnership with Kardi AI for cardiac monitoring services deployment in target markets.
• HITLABcoreStrategic or Co-development PartnerKardi AI is pursuing FDA pathway in cooperation with HITLAB, a healthcare innovation research organization, to support US market entry regulatory requirements.
• CzechInvestsupportOthersCzechInvest supports Kardi AI through national programs for innovation development, technology advancement, and international expansion, including NPO certification and internationalization programs.
• European UnionsupportOthersKardi AI received EU funding support through European Regional Development Fund and national operational programs for digital economy and innovative startups.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Boston Scientific: Boston Scientific acquired Preventice Solutions, a provider of ambulatory ECG monitors (BodyGuardian), giving it a foothold in the same long-term cardiac monitoring market Kardi Ai targets. Serves the same cardiology/hospital channel but as part of a much broader device portfolio.
• Philips (BioTelemetry / Cardiac Care): Philips, through BioTelemetry, is a leading provider of remote cardiac monitoring services (MCOT, Holter) with established hospital channels and payor relationships globally. Overlaps with Kardi Ai in long-term ambulatory ECG monitoring but operates at much larger scale across multiple monitoring modalities.
• GE Healthcare (MUSE / ECG): GE Healthcare is a global incumbent in cardiology diagnostics, with MUSE cardiology information systems, resting ECG, and Holter products sold to hospitals and clinics. While not directly competing in the consumer single-lead segment, it competes in the same downstream cardiology workflow that Kardi Ai's physician portal feeds into.
• Baxter (Bardy Diagnostics / Hillrom): Baxter (via Hillrom/BardyDx) offers the Carnation Ambulatory Monitor, a patch-based long-term ECG monitor with AI analysis. Comparable to Kardi Ai in long-duration single-lead ambulatory ECG and AI arrhythmia detection, but distributed through Baxter's large hospital sales infrastructure.

Emerging players

• Qardio: Qardio produces consumer ECG and remote patient monitoring devices (QardioCore chest strap, QardioArm blood pressure). Comparable to Kardi Ai in the consumer-facing wearable ECG and remote cardiac monitoring category, though positioned more as a wellness/RPM platform than a certified diagnostic.
• Withings: Withings produces consumer health devices including Move ECG (single-lead ECG watch/scale) with a companion app that detects AF. Comparable to Kardi Ai in consumer ECG hardware and app-driven arrhythmia screening, though positioned more as a wellness device than a certified diagnostic.
• Eko Health: Eko Health makes AI-enabled digital stethoscopes with ECG and cardiac abnormality detection algorithms (FDA-cleared). Comparable to Kardi Ai in AI-driven cardiac signal analysis, though delivered through a clinician-facing stethoscope form factor rather than a consumer wearable.

Direct peers

• AliveCor: AliveCor's KardiaMobile is a consumer/single-lead ECG device paired with an AI-driven arrhythmia detection app, FDA-cleared and widely prescribed. It is the closest direct peer to Kardi Ai in terms of single-lead ECG hardware, mobile app, AI arrhythmia detection, and consumer-plus-clinician distribution model.
• iRhythm Technologies: iRhythm's Zio long-term continuous ECG patch (up to 14 days) is a prescription-based cardiac monitor with AI-assisted analysis. Direct peer in long-duration ambulatory ECG monitoring for arrhythmia detection, addressing the same Holter-replacement use case that Kardi Ai targets.
• Coala Life: Coala Life is a Swedish ECG remote monitoring company with a chest-mounted device and cloud-based AI analysis for arrhythmia detection. Highly comparable to Kardi Ai in product form factor (chest ECG), AI-based analysis, and Nordic/CE-certification-led GTM.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights8 records

Customer concentration

• Facebookfacebook.com/KardiAI
• LinkedInlinkedin.com/company/kardi-ai
• YouTubeyoutube.com/channel/UCjQtVdH1v8DaxLdfX3GznlQ

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds4 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kardi Ai